Sheng L - Search Results

1

Discovery of novel PTP1B inhibitors with antihyperglycemic activity.

Liu Z, Chai Q, Li YY, Shen Q, Ma LP, Zhang LN, Wang X, Sheng L, Li JY, Li J, Shen JK. Liu Z, et al. Among authors: sheng l. Acta Pharmacol Sin. 2010 Aug;31(8):1005-12. doi: 10.1038/aps.2010.81. Acta Pharmacol Sin. 2010. PMID: 20686525 Free PMC article.

2

8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models.

Cheng Z, Chen AF, Wu F, Sheng L, Zhang HK, Gu M, Li YY, Zhang LN, Hu LH, Li JY, Li J. Cheng Z, et al. Among authors: sheng l. Bioorg Med Chem. 2010 Aug 15;18(16):5915-24. doi: 10.1016/j.bmc.2010.06.085. Epub 2010 Jul 1. Bioorg Med Chem. 2010. PMID: 20663675

3

A unique and rapid approach toward the efficient development of novel protein tyrosine phosphatase (PTP) inhibitors based on 'clicked' pseudo-glycopeptides.

Yang JW, He XP, Li C, Gao LX, Sheng L, Xie J, Shi XX, Tang Y, Li J, Chen GR. Yang JW, et al. Among authors: sheng l. Bioorg Med Chem Lett. 2011 Feb 15;21(4):1092-6. doi: 10.1016/j.bmcl.2010.12.126. Epub 2010 Dec 31. Bioorg Med Chem Lett. 2011. PMID: 21251827

4

Synthesis of novel 6-triazologlycolipids via click chemistry and their preliminary cytotoxicity assessments.

Zhang HL, He XP, Sheng L, Yao Y, Zhang W, Shi XX, Li J, Chen GR. Zhang HL, et al. Among authors: sheng l. Mol Divers. 2011 Nov;15(4):889-900. doi: 10.1007/s11030-011-9318-1. Epub 2011 Jun 5. Mol Divers. 2011. PMID: 21643967

5

Synthesis and biological evaluation of piperamide analogues as HDAC inhibitors.

Luo Y, Liu HM, Su MB, Sheng L, Zhou YB, Li J, Lu W. Luo Y, et al. Among authors: sheng l. Bioorg Med Chem Lett. 2011 Aug 15;21(16):4844-6. doi: 10.1016/j.bmcl.2011.06.046. Epub 2011 Jun 17. Bioorg Med Chem Lett. 2011. PMID: 21745740

6

Diterpenes from the Hainan soft coral Lobophytum cristatum Tixier-Durivault.

Li L, Sheng L, Wang CY, Zhou YB, Huang H, Li XB, Li J, Mollo E, Gavagnin M, Guo YW. Li L, et al. Among authors: sheng l. J Nat Prod. 2011 Oct 28;74(10):2089-94. doi: 10.1021/np2003325. Epub 2011 Sep 28. J Nat Prod. 2011. PMID: 21954851

7

The anomeric mixture of some O-galactolipid derivatives is more toxic against cancer cells than either anomer alone.

Song SX, Wu ML, He XP, Zhou YB, Sheng L, Li J, Chen GR. Song SX, et al. Among authors: sheng l. Bioorg Med Chem Lett. 2012 Mar 1;22(5):2030-2. doi: 10.1016/j.bmcl.2012.01.069. Epub 2012 Jan 28. Bioorg Med Chem Lett. 2012. PMID: 22326167

8

Synthesis and in vitro cytotoxic evaluation of novel N-(3,4,5-trimethoxyphenyl)pyridin-2(1H)-one derivatives.

Chen T, Luo Y, Sheng L, Li J, Hu Y, Lu W. Chen T, et al. Among authors: sheng l. Mol Divers. 2013 Aug;17(3):435-44. doi: 10.1007/s11030-013-9442-1. Epub 2013 Apr 24. Mol Divers. 2013. PMID: 23612851

9

The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase.

Zhang X, Bao B, Yu X, Tong L, Luo Y, Huang Q, Su M, Sheng L, Li J, Zhu H, Yang B, Zhang X, Chen Y, Lu W. Zhang X, et al. Among authors: sheng l. Bioorg Med Chem. 2013 Nov 15;21(22):6981-95. doi: 10.1016/j.bmc.2013.09.023. Epub 2013 Sep 18. Bioorg Med Chem. 2013. PMID: 24095018

10

Curcusone D, a novel ubiquitin-proteasome pathway inhibitor via ROS-induced DUB inhibition, is synergistic with bortezomib against multiple myeloma cell growth.

Cao MN, Zhou YB, Gao AH, Cao JY, Gao LX, Sheng L, Xu L, Su MB, Cao XC, Han MM, Wang MK, Li J. Cao MN, et al. Among authors: sheng l. Biochim Biophys Acta. 2014 Jun;1840(6):2004-13. doi: 10.1016/j.bbagen.2014.02.006. Epub 2014 Feb 15. Biochim Biophys Acta. 2014. PMID: 24534329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,182 results

Search Page

Filters